Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 4
1966 11
1967 9
1968 11
1969 8
1970 21
1971 21
1972 21
1973 14
1974 22
1975 17
1976 23
1977 21
1978 35
1979 33
1980 38
1981 21
1982 20
1983 39
1984 47
1985 51
1986 66
1987 75
1988 81
1989 101
1990 103
1991 120
1992 106
1993 131
1994 157
1995 173
1996 192
1997 163
1998 188
1999 212
2000 234
2001 212
2002 214
2003 212
2004 216
2005 239
2006 248
2007 255
2008 278
2009 248
2010 261
2011 252
2012 255
2013 249
2014 278
2015 223
2016 236
2017 232
2018 201
2019 149
2020 160
2021 78
Text availability
Article attribute
Article type
Publication date

Search Results

6,616 results
Results by year
Filters applied: . Clear all
Page 1
PROMISE: first-trimester progesterone therapy in women with a history of unexplained recurrent miscarriages - a randomised, double-blind, placebo-controlled, international multicentre trial and economic evaluation.
Coomarasamy A, Williams H, Truchanowicz E, Seed PT, Small R, Quenby S, Gupta P, Dawood F, Koot YE, Atik RB, Bloemenkamp KW, Brady R, Briley A, Cavallaro R, Cheong YC, Chu J, Eapen A, Essex H, Ewies A, Hoek A, Kaaijk EM, Koks CA, Li TC, MacLean M, Mol BW, Moore J, Parrott S, Ross JA, Sharpe L, Stewart J, Trépel D, Vaithilingam N, Farquharson RG, Kilby MD, Khalaf Y, Goddijn M, Regan L, Rai R. Coomarasamy A, et al. Health Technol Assess. 2016 May;20(41):1-92. doi: 10.3310/hta20410. Health Technol Assess. 2016. PMID: 27225013 Free PMC article. Clinical Trial.
Additional sensitivity analysis suggested the probability that progesterone would fall within the National Institute for Health and Care Excellence's threshold of 20,000-30,000 per quality-adjusted life-year as between 0.7145 and 0.7341. CONCLUSIONS: There is no evi …
Additional sensitivity analysis suggested the probability that progesterone would fall within the National Institute for Health and C …
Pharmacokinetics of vaginal progesterone in pregnancy.
Boelig RC, Zuppa AF, Kraft WK, Caritis S. Boelig RC, et al. Am J Obstet Gynecol. 2019 Sep;221(3):263.e1-263.e7. doi: 10.1016/j.ajog.2019.06.019. Epub 2019 Jun 15. Am J Obstet Gynecol. 2019. PMID: 31211965 Free PMC article. Clinical Trial.
BACKGROUND: Characterization of pharmacokinetics is lacking for vaginal progesterone in pregnancy. Dosing of vaginal progesterone for preterm birth prevention has been empirical. ...Serum progesterone is unlikely to be a good candidate for establishing pharma …
BACKGROUND: Characterization of pharmacokinetics is lacking for vaginal progesterone in pregnancy. Dosing of vaginal progesterone
A Phase III randomized controlled trial comparing the efficacy, safety and tolerability of oral dydrogesterone versus micronized vaginal progesterone for luteal support in in vitro fertilization.
Tournaye H, Sukhikh GT, Kahler E, Griesinger G. Tournaye H, et al. Hum Reprod. 2017 May 1;32(5):1019-1027. doi: 10.1093/humrep/dex023. Hum Reprod. 2017. PMID: 28333318 Free PMC article. Clinical Trial.
G.S. has nothing to disclose. E.K. is an employee of Abbott GmbH. ...TRIAL REGISTRATION DATE: 19 April 2013. DATE OF FIRST PATIENT'S ENROLLMENT: 23 August 2013....
G.S. has nothing to disclose. E.K. is an employee of Abbott GmbH. ...TRIAL REGISTRATION DATE: 19 April 2013. DATE OF FIRST PATIENT' …
Early vaginal progesterone versus placebo in twin pregnancies for the prevention of spontaneous preterm birth: a randomized, double-blind trial.
Rehal A, Benkő Z, De Paco Matallana C, Syngelaki A, Janga D, Cicero S, Akolekar R, Singh M, Chaveeva P, Burgos J, Molina FS, Savvidou M, De La Calle M, Persico N, Quezada Rojas MS, Sau A, Greco E, O'Gorman N, Plasencia W, Pereira S, Jani JC, Valino N, Del Mar Gil M, Maclagan K, Wright A, Wright D, Nicolaides KH. Rehal A, et al. Am J Obstet Gynecol. 2021 Jan;224(1):86.e1-86.e19. doi: 10.1016/j.ajog.2020.06.050. Epub 2020 Jun 26. Am J Obstet Gynecol. 2021. PMID: 32598909 Free article. Clinical Trial.
Such apparent lack of effectiveness of progesterone in twins may be due to inadequate dosage or treatment that is started too late in pregnancy. ...A post hoc analysis using mixed-effects Cox regression was used for further exploration of the effect of progesterone
Such apparent lack of effectiveness of progesterone in twins may be due to inadequate dosage or treatment that is started too late in …
Progesterone and threatened abortion: a randomized clinical trial on endocervical cytokine concentrations.
Alimohamadi S, Javadian P, Gharedaghi MH, Javadian N, Alinia H, Khazardoust S, Borna S, Hantoushzadeh S. Alimohamadi S, et al. J Reprod Immunol. 2013 Jun;98(1-2):52-60. doi: 10.1016/j.jri.2013.01.004. Epub 2013 Mar 13. J Reprod Immunol. 2013. PMID: 23489467 Clinical Trial.
A significant decrease in IFNgamma and increase in IL-10 in endocervical fluid was seen when the values were compared before and after progesterone treatment. However, there were no significant differences in pregnancy outcomes between the placebo and progesterone g …
A significant decrease in IFNgamma and increase in IL-10 in endocervical fluid was seen when the values were compared before and after pr
Combined treatment with cervical pessary and vaginal progesterone for the prevention of preterm birth: A randomized clinical trial.
Karbasian N, Sheikh M, Pirjani R, Hazrati S, Tara F, Hantoushzadeh S. Karbasian N, et al. J Obstet Gynaecol Res. 2016 Dec;42(12):1673-1679. doi: 10.1111/jog.13138. Epub 2016 Oct 8. J Obstet Gynaecol Res. 2016. PMID: 27718280 Clinical Trial.
AIM: We compared the effectiveness of a combined treatment involving cervical pessary plus vaginal progesterone to vaginal progesterone alone in decreasing the rate of preterm birth in women with short cervix in the second gestational trimester. ...Seventy-three pat …
AIM: We compared the effectiveness of a combined treatment involving cervical pessary plus vaginal progesterone to vaginal progest
A clinical trial of progesterone for severe traumatic brain injury.
Skolnick BE, Maas AI, Narayan RK, van der Hoop RG, MacAllister T, Ward JD, Nelson NR, Stocchetti N; SYNAPSE Trial Investigators. Skolnick BE, et al. N Engl J Med. 2014 Dec 25;371(26):2467-76. doi: 10.1056/NEJMoa1411090. Epub 2014 Dec 10. N Engl J Med. 2014. PMID: 25493978 Free article. Clinical Trial.
We investigated the efficacy and safety of progesterone in a large, prospective, phase 3 randomized clinical trial. ...No relevant safety differences were noted between progesterone and placebo. CONCLUSIONS: Primary and secondary efficacy analyses showed no clinical …
We investigated the efficacy and safety of progesterone in a large, prospective, phase 3 randomized clinical trial. ...No relevant sa …
Comparison between the effects of progesterone versus corticosteroid local injections in mild and moderate carpal tunnel syndrome: a randomized clinical trial.
Bahrami MH, Shahraeeni S, Raeissadat SA. Bahrami MH, et al. BMC Musculoskelet Disord. 2015 Oct 26;16:322. doi: 10.1186/s12891-015-0752-6. BMC Musculoskelet Disord. 2015. PMID: 26502966 Free PMC article. Clinical Trial.
BACKGROUND: The objective of this study was to compare the short-term effects of progesterone and corticosteroid local injections in the treatment of female patients with carpal tunnel syndrome. ...Patients were treated with a single local injection of triamcinolone aceton …
BACKGROUND: The objective of this study was to compare the short-term effects of progesterone and corticosteroid local injections in …
Effects of progesterone therapy on serum sclerostin levels in healthy menopausal women: a 3-month randomized, placebo-controlled clinical trial.
Yang YB, Goshtasebi A, van Lierop AH, Kalidasan D, Hitchcock CL, Prior JC. Yang YB, et al. Osteoporos Int. 2020 Nov;31(11):2243-2250. doi: 10.1007/s00198-020-05505-x. Epub 2020 Jun 20. Osteoporos Int. 2020. PMID: 32564093 Clinical Trial.
Sclerostin, a natural hormone made in bone, suppresses bone formation. Sclerostin is also decreased by estrogen. Progesterone, estrogen's menstrual partner, stimulates bone formation. It is unclear whether progesterone influences sclerostin. This study showed …
Sclerostin, a natural hormone made in bone, suppresses bone formation. Sclerostin is also decreased by estrogen. Progesterone, estrog …
Progesterone and Postpartum Smoking Relapse: A Pilot Double-Blind Placebo-Controlled Randomized Trial.
Allen SS, Allen AM, Lunos S, Tosun N. Allen SS, et al. Nicotine Tob Res. 2016 Nov;18(11):2145-2153. doi: 10.1093/ntr/ntw156. Epub 2016 Aug 18. Nicotine Tob Res. 2016. PMID: 27613934 Free PMC article. Clinical Trial.
This pilot study evaluates the feasibility and potential role of exogenous progesterone in postpartum smoking relapse. METHODS: This 12-week double-blind placebo-controlled randomized pilot trial randomized 46 abstinent postpartum women to active progesterone (PRO; …
This pilot study evaluates the feasibility and potential role of exogenous progesterone in postpartum smoking relapse. METHODS: This …
6,616 results